Search clinical trials for: Anti-CD38

Total 97314 results

Databean
Octapharma

Terminated

A Prospective, Global, Multi-center, Treatment Registry Study of Intravenous Immunoglobulin Maintenance Therapy in Alloantibody Positive Renal Allograft Recipients (DSA)

Renal Transplant Recipients With Anti-HLA Antibodies

United States
Zhejiang ACEA Pharmaceutical Co. Ltd.

Recruiting

Safety and Efficacy Study of An Anti-CD38 Antibody Drug Conjugate in Relapsed or Refractory Multiple Myeloma

Relapsed or Refractory Multiple Myeloma

China
University Hospital Ostrava

Recruiting

Molecular Characteristics and Prevalence of Viral Hepatitis E in Human Tissue and Cell Donors

Hepatitis E

Czechia
Shenzhen Geno-Immune Medical Institute
The Seventh Affiliated Hospital of Sun Yat-sen University; Shenzhen Children... and other collaborators

Recruiting

4SCAR-T Therapy Post CD19-targeted Immunotherapy

CD19 Negative B-cell Malignancies

China
Kingman Regional Medical Center

Completed

Prevalence of COVID-19 Antibodies Kingman AZ

Covid19

United States
Sorrento Therapeutics, Inc.

Recruiting

Study to Assess Allogeneic Anti-CD38 A2 Dimeric Antigen Receptor T Cells in Relapsed or Refractory Multiple Myeloma

Multiple Myeloma

United States
China Medical University, China

Withdrawn

Diluting With Cerebrospinal Fluid Versus Traditional Intrathecal Administration: Antishivering Effects

Antishivering Effects

China
Clinique Ovo

Terminated

Anti-Mullerian Hormone Levels Before and After an Open Myomectomy

Anti-Mullerian Hormone

Canada
Janssen Research & Development, LLC

Completed

Whole Blood and Plasma Sample Collection for the Development of Antipsychotic Immunoassays From Participants Taking Aripiprazole, Olanzapine, Paliperidone, or Risperidone

Immunoassay | Antipsychotic

Belgium
Fotona d.o.o.

Unknown

Intraurethral/Intravaginal 2940 nm Erbium Laser Treatment For Stress Urinary Incontinence

Stress Urinary Incontinence

Canada
Bristol-Myers Squibb

Active, not recruiting

An Investigational Immuno-therapy Study to Assess the Safety, Tolerability and Effectiveness of Anti-LAG-3 With and Without Anti-PD-1 in the Treatment of Solid Tumors

Neoplasms by Site

United States, Australia, Denmark, France, Switzerland, Austria, Canada, Germany, Japan, Netherlands, Norway, Spain, United Kingdom, Finland, Italy
Assistance Publique - Hôpitaux de Paris

Recruiting

Current Use in Intensive Care Units by Intensivists of Antihypertensive Drugs (CUICUI-AHD)

Antihypertensive Drugs in ICU

France
Fondation Ophtalmologique Adolphe de Rothschild

Terminated

Use of QTRAC Technique to Measure Axonal Excitability in Anti-MAG Neuropathy (EXCIMAG)

Peripheral Neuropathy Associated With Anti-myelin Associated Glycoprotein Antibodies (Anti-MAG Neuropathy)

France
Georgetown University
Bristol-Myers Squibb; Targovax ASA; Janssen, LP

Recruiting

Anti-CD38 Antibody With KRAS Vaccine and Anti-PD-1 Antibody in Subjects With Pancreatic Ductal Adenocarcinoma and Refractory Non-Small Cell Lung Cancer (DARANIVOVAX)

Pancreatic Ductal Adenocarcinoma | Refractory Non-Small Cell Lung Cancer

United States
Hangzhou Sumgen Biotech Co., Ltd.

Recruiting

SG2501 Safety Study in Subjects With Relapsed or Refractory Hematological Malignancies and Lymphoma.

Lymphoma | Hematological Malignancy

United States
Jennifer Woyach

Active, not recruiting

Daratumumab and Ibrutinib in Treating Patients With Symptomatic Chronic Lymphocytic Leukemia

Chronic Lymphocytic Leukemia

United States
Cardiovascular Academy Society, Turkey

Completed

Demographical and Clinical Profile of Patients on Dual Antıplatelet Therapy and Mean Precise-DAPT and DAPT Scores in Turkey

Anti-platelet Therapy

Turkey
Hospices Civils de Lyon

Recruiting

Clinical Characterization and Outcome of Anti-IgLON5 Disease (ICP-IGLON5)

Anti-IgLON5 Disease

France
Chiang Mai University

Completed

Appropriateness of Intravenous Antibiotics Prescriptions at Hospital Discharge

Anti-Infectives Adverse Reaction

Thailand
Shenzhen Geno-Immune Medical Institute
Yunnan Cancer Hospital; Zhujiang Hospital, Southern Medical University, Guangzhou...

Unknown

Multi-CAR T Cell Therapy for Acute Myeloid Leukemia

Acute Myeloid Leukemia

China
HI-Bio

Completed

Clinical Trial to Assess Efficacy and Safety of the Human Anti-CD38 Antibody Felzartamab (MOR202) in IgA Nephropathy (IGNAZ)

Immunoglobulin A (IgA) Nephropathy

United Kingdom, Germany, Spain, Serbia, Taiwan, Australia, Japan, Korea, Republic of, Belgium, United States, Bulgaria, Czechia, Georgia, Malaysia, Philippines, Ukraine
Shenzhen Geno-Immune Medical Institute
The Second Affiliated Hospital of Hainan Medical University; Beijing Jingdu...

Recruiting

Universal CAR-T Cells Targeting AML

Acute Myeloid Leukemia

China
Daniela Matei, MD
Merck Sharp & Dohme LLC; Hoosier Cancer Research Network

Completed

Pembro/Carbo/Taxol in Endometrial Cancer

Endometrial Cancer | Endometrial Adenocarcinoma

United States
Amazentis SA
proDERM GmbH

Completed

Evaluation of the Anti-aging Efficacy of Four Skin Health Products

Skin Aging | Anti-Aging

Germany
ART Fertility Clinics LLC

Completed

Measurement of Different Anti-Müllerian Hormone Isoforms in Expected Poor Responders

Anti-Mullerian Hormone Isoforms

United Arab Emirates
ART Fertility Clinics LLC

Completed

Evaluating the AMH Levels During Natural Cycle

Anti-Mullerian Hormone Resistance

United Arab Emirates
Memorial Sloan Kettering Cancer Center

Withdrawn

A Study of PET/CT Scans With the Radioactive Tracer 89Zr-DFO-Daratumumab in People With Myeloma

Multiple Myeloma
Assistance Publique - Hôpitaux de Paris
Etablissement Français du Sang (Nouvelle Aquitaine)

Recruiting

Obstetrical History and Anti-HLA Antibodies Level (OBS-HLA)

Blood Donors | Anti-HLA Antibody

France
Ottawa Hospital Research Institute

Completed

Anticholinergic Risk Scale and Resource Use After Elective Noncardiac Surgery

Aged | Length of Stay | Epidemiology | Surgical Procedure, Operative | Anti Cholinergics

Canada
Samsung Medical Center

Unknown

The Impact of Gynecological Surgery on Ovarian Function in Women of Reproductive Age: Postoperative Changes of Serum Anti-Müllerian Hormone (AMH)

Ovarian Reserve | Gynecologic Operations | Anti-Mullerian Hormone
CONRAD
United States Agency for International Development (USAID); Agility Clinical...

Completed

Safety, PK, and PD Study of IVRs Releasing TFV and LNG (TFV/LNG IVR)

Contraceptive Usage | Anti-Infective Agents | Anti-Retroviral Agents

Dominican Republic, United States
ANRS, Emerging Infectious Diseases

Completed

Lipopeptide Immunisation With GTU-multiHIV Trial

HIV-1 Infection

France
Hannover Medical School

Recruiting

Monitoring of Donor-specific Antibodies After Treatment With Immunoglobulins, Plasmapheresis and Rituximab in Lung Transplantation

Lung Transplantation | Donor-specific Anti-human Leukocyte Antigen(HLA) Antibodies

Germany
Poznan University of Medical Sciences
University at Buffalo; The Greater Poland Cancer Centre

Active, not recruiting

Translational PKPD Modeling of Anti-infective Drugs Used in Pediatric Units.

Population Modeling of Anti-infective Drugs

Poland
Genmab
AbbVie

Terminated

First-in-Human (FIH) Trial of GEN3009 in Subjects With Relapsed or Refractory B-Cell Non-Hodgkin Lymphomas

Follicular Lymphoma | Mantle Cell Lymphoma | Marginal Zone Lymphoma | Chronic Lymphocytic Leukemia | Diffuse Large B-cell Lymphoma | Small Lymphocytic Lymphoma | High-grade B-cell Lymphoma | Primary Mediastinal Large B-cell Lymphoma

United States, Spain, Netherlands, Belgium, France, Denmark
Johns Hopkins Bloomberg School of Public Health
United States Department of Defense; Naval Medical Research Center

Completed

Efficacy of B7A BSIgG Against E. Coli Strain B7A Challenge

Healthy Volunteer

United States
Hamilton Health Sciences Corporation
McMaster University; BSN Medical Inc

Completed

Graduated Compression Stockings (GCS) Pilot Substudy

Venous Thromboembolism

Canada
Bayer
Corporación Bonima S.A. de C.V.

Completed

Cross Over Study to Prove Bioequivalence Between Two Brands of Cefalexin Suspension

Anti-Infective Agents

Mexico
African Malaria Network Trust
London School of Hygiene and Tropical Medicine

Unknown

A Phase Ib Trial of MSP 3 LSP in 1-2 Year Old Children in Burkina Faso (MSP3LSP)

Malaria

Burkina Faso
Memorial Sloan Kettering Cancer Center

Completed

First-in- Human Imaging of Multiple Myeloma Using 89Zr-DFO-daratumumab, a CD38-targeting Monoclonal Antibody

Multiple Myeloma

United States
Assiut University

Not yet recruiting

Use of Antiarrhythmic Drugs in Pediatrics

Antiarrhythmic Toxicity
Humanis Saglık Anonim Sirketi

Completed

Bioequivalence Study to Compare Diclofenac Potassium Coated Tablet Versus Cataflam® 50 Coated Tablet

Analgesic | Non-steroidal Anti-inflammatory (NSAID) | Antipyretic

Jordan
Shanghai Henlius Biotech

Active, not recruiting

A Study to Compare the PK , Safety, Tolerability, and Immunogenicity of HLX15 With Daratumumab in Male Subjects

Multiple Myeloma

China
Hanyang University Seoul Hospital
Seegene Medical Foundation

Completed

Protective Antibody Level After COVID-19 Vaccination Among Patients Under Hemodialysis

Covid19 | Vaccine Reaction | Hemolysis | End-stage Renal Disease

Korea, Republic of
University of North Carolina, Chapel Hill
UNC Institute for Pharmacogenomics and Individualized Therapy

Completed

Genotype-Guided Warfarin Therapy Trial (WARFPGX)

Atrial Fibrillation | Deep Vein Thrombosis | Pulmonary Embolism | Artificial Heart Valve

United States
Bayer
Corporación Bonima S.A. de C.V.

Completed

Cross-over Study to Prove Bioequivalence Between Two Brands of Cefalexin Suspension

Anti-Infective Agents

Mexico
Allergan

Completed

A Clinical Study to Evaluate if Benzalkonium Chloride (BAK) in a Quinolone Eyedrop Reduces the Likelihood of Developing Resistant Organisms

Anti-biotic Resistance

United States, Canada
Zhujiang Hospital
The Third Affiliated Hospital of Southern Medical University; Sun Yat-Sen Memorial... and other collaborators

Terminated

CAR-T Cells Therapy in Relapsed/Refractory Multiple Myeloma (MM)

Relapsed/Refractory Multiple Myeloma(MM)

China
Chiang Mai University

Completed

Carbapenems De-escalation as Antimicrobial Stewardship

Anti-Bacterial Agents
Bausch Health Americas, Inc.

Completed

(C2013-0302) Safety and Efficacy of Escalating Doses of SAN-300 in Patients With Rheumatoid Arthritis

Rheumatoid Arthritis

United States

Search clinical trials for: Anti-CD38

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Poland

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations